Abstract Ketanserin (KT), an antihypertensive agent, has been shown to prolong action potential duration (APD) and QT interval and to induce torsade de pointes in some patients. We previously suggested that the prolongation of APD could be due to KT inhibition of the fast component of the delayed rectifier current (IKr) in guinea-pig myocytes. However, in other tissue such as human atrium, Purkinje fibers, epicardial cells, and rat ventricular myocytes, the transient outward potassium current (ItO) is one of the major repolarizing currents. We investigated the possibility that KT could also increase APD by blocking 'to. Action potentials and membrane currents were recorded from rat ventricular myocytes known to have a large ItO by using whole-cell patch-clamp techniques. We found that KT (50 gmol/L) significantly prolonged APD at 50% repolarization by 218% (P<.05) the cardiac action potential of several mammalian tissues, including human atrium10 l" and rabbit, dog, and rat ventricular myocytes.12-"6 In these preparations, it is possible that KT could alter APD by interacting with ,to.
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Abstract Ketanserin (KT), an antihypertensive agent, has been shown to prolong action potential duration (APD) and QT interval and to induce torsade de pointes in some patients. We previously suggested that the prolongation of APD could be due to KT inhibition of the fast component of the delayed rectifier current (IKr) in guinea-pig myocytes. However, in other tissue such as human atrium, Purkinje fibers, epicardial cells, and rat ventricular myocytes, the transient outward potassium current (ItO) is one of the major repolarizing currents. We investigated the possibility that KT could also increase APD by blocking 'to. Action potentials and membrane currents were recorded from rat ventricular myocytes known to have a large ItO by using whole-cell patch-clamp techniques. We found that KT (50 gmol/L) significantly prolonged APD at 50% repolarization by 218% (P<.05) and APD at 90% repolarization by 256% (P<.05) with no significant effect on other action potential parameters. Time-dependent It,, and sustained current (ISUS) were measured in the presence of 400 nmol/L nisoldipine during depolarizing pulses to 40 mV from a holding potential of -100 mV every 10 seconds. KT resulted in a concentration-and time-dependent inhibition of charge area of It, evaluated by integration with an EC50 of 8.3 ,umol/L. The inhibitory effect of KT (10 ,umol/L) was seen at voltages from 0 to 80 mV without any shift of the current-voltage relation of peak 1, KT did not significantly change activation, inactivation, and reactivating curves of ,to. Kinetic analysis of Ito showed a biexponential fit of inactivation in 80.5% of total tracings studied at voltages between -30 and 80 mV (n= 149, R=.99+.01). The inhibitory effect of KT was more prominent on charge areas of the slow component (Qs) than the fast component (Qf) of Ito (Qf=33.2+6.2 s . pA and Q =235.5 +7. 4 K etanserin (KT), both serotonin and weak alreceptor antagonist, has been evaluated for the treatment of hypertension and peripheral vascular disease.12 In the heart, KT has been found to markedly prolong the action potential duration (APD) in rabbit ventricular myocardium,3 canine ventricular muscle, and Purkinje fibers. 4 In addition, prolongation of the QT interval has been reported in KT-treated patients. [5] [6] [7] The antiarrhythmic action of KT in ischemic/reperfused rat heart has been ascribed to a prolongation of APD. 8 Recently, we reported that KT prolongs APD by exerting an open channel block of the fast component of the delayed rectifier potassium current (IKr) in guinea pig ventricular myocytes, with little or no effect on the inward rectifier potassium current (IK1) .9 It has been shown that transient potassium outward current (Ito) is the major outward repolarizing current in ferred to a 500-,uL chamber mounted on the stage of an inverted microscope (Nikon Inc). Rod-shaped noncontracting cells with clear striations were used for the whole-cell voltageclamp studies. All experiments were carried out at room temperature (20°C to 22°C).
Solutions and Drugs
The compositions of external and internal solutions for recording action potential, potassium, and calcium currents are given in the Table. For potassium current recordings, NaCl was replaced by choline chloride in the external solution to eliminate the fast inward sodium current (INa).'9 Since only L-type calcium current (ICa) was found (authors' unpublished data) and reported in adult rat ventricular cells by others,20 the calcium channel blocker nisoldipine (400 nmol/L) was added to the external solution.21 For lCa recording, 50 ,umol/L tetrodotoxin and 5 mmol/L 4-aminopyridine were added to the external solution to block INa and ,tot respectively, as previously described. 18 The pH values of external and internal solutions were adjusted to 7.4 and 7.1, respectively. KT was obtained from Janssen Research Foundation and dissolved in distilled water as a stock solution of 10 mmol/L. All drugs are from Sigma Chemical Co unless otherwise indicated.
Voltage-Clamp Recording
Whole-cell current-and voltage-clamp recording techniques were used22 to record action potentials and membrane ionic currents,23 respectively. A programmable horizontal puller (model P-87, Sutter Instrument Co) was used to pull the electrodes. The resistance of the capillary glass electrodes (Drummond Scientific Co) used was 1 to 3 M[Q when filled with internal solution (electrode tip, 1 to 2 ,um). The volume of the recording chamber was 0.5 mL, and the rate of superfusion was 3 mL/min. The junction potential was always compensated and was <5 mV. Membrane currents were recorded with a Dagan model 3900A patch-clamp amplifier (Dagan Corp). Capacitive currents were elicited by 10-mV depolarizing pulse from -80 mV and then compensated. Later on, the capacitive tracings were fitted by a single exponential equation, and membrane capacitance (Cm) was calculated according to the Aequation Cm= rT 1*/AEm, where r, is the time constant for cell membrane charge, I. is maximum capacitive current, and IAEm is clamp voltage. The average Cm was 145.3±10.3 pF (n=28). Under current-clamp conditions, the action potential was elicited by passing a current pulse through the recording patch electrode (5-to 10-millisecond duration, two times threshold). Under voltage-clamp conditions, the cells were stimulated at 0.1 Hz to ensure that I. and Ic, were recovered completely between two voltage steps. Action potentials were also recorded at 0.1 Hz under the current-clamp mode. Membrane currents were generated by using appropriate protocols as indicated in "Results."
Because extracellular choline chloride (sodium ion substitute) has been found to shift the voltage-dependent inactivation curve of I, to the left (negative potentials), a holding potential of -100 mV was used to record the fully activated Ito.19 To ensure that nisoldipine block of Ica at a holding potential of -100 mV was complete,24 we first recorded current tracings (ICa) in control external solution usually used to record It,, in the absence of nisoldipine by an 800-millisecond depolarizing pulse from a holding potential of -40 mV to a test pulse of 0 mV, where 'Ca is maximally activated. 18 The current tracing obtained by this protocol corresponded to 1Ca and is shown in Fig 1A, the maximum block of charge area of Ito, EC50 is the concentration of KT for half-maximum block, D is the concentration of KT, and n is the Hill coefficient. The charge area, Q, was calculated as the integral under the time-dependent inactivated membrane current (see Fig 9) . Computer-simulated current tracings were generated by Equations 2 and 3 shown in "Discussion." Data are presented as mean+SEM. Student's t test for paired data was used to compare control conditions with drug interventions. A value of P< .05 was considered to be statistically significant. (tracing c). These tracings were taken from panel B at the times indicated. B, Graph illustrates the time course of KT effect on lto from a cell that was initially superfused with control external solution (CON) for 2 minutes, followed by superfusion with a solution containing KT The steady-state inactivation was generated by holding the membrane at different potentials ranging from -120 to -10 mV for 1000 milliseconds before applying the test potential at a fixed voltage of 60 mV. 
Results

Prolongation of APD by KT in
Effect of KT on Kinetic Properties of IO
We analyzed the reactivation of 'to evoked by a 600-millisecond depolarizing pulse at 60 mV from a holding potential of -100 mV, followed by the same depolarizing pulse at variable resting intervals ranging from 10 to 650 milliseconds. Current tracings obtained from such a protocol are illustrated in Fig 8A in On the other hand, Duan et a126 found that ISUS, in rabbit atrial myocytes, was insensitive to TEA and barium but was reduced by the chloride transport blockers, suggesting the involvement of a noninactivating chloride current. In the present study, KT reduced both components of the outward current (Fig 11, upper panel) Therefore, an effect of KT on such a current cannot be excluded.
KT also has a serotonin S2-receptor antagonist and weak a1-adrenergic antagonist effects. 36 The present reported KT effects are unlikely to be mediated through these receptors because KT was tested in the absence of any S2-or a1-receptor agonist in isolated myocytes.
The finding that KT can inhibit IKr, Ito, and ISuS can have obvious pharmacotherapeutic implications. KT is used as an effective antihypertensive agent in patients with essential hypertension. However, a potential cardiotoxic effect associated with the marked prolongation of the QT interval and the induction of the malignant ventricular arrhythmia, torsade de pointes, especially in settings of electrolyte imbalance, cannot be excluded.
